I liked Peter Munk. He was clever. Don't care for Soros but like Munk he has friends in high places. Abeo could be good for 3 points easy, since Russell global indices also have to buy it and report by month's end since it was added to indices. And yes, that's a fact. Keep an eye on ABEO because when the momo gets going it's a beauty. Just sayin'.
as for ABX, nibbling here but prefer KGC as a takeover target.
I may not like him but sure as heck wouldn't bet against him, and his track record.
Last time this news came out when he bought first 5% it ran over 11 :-)
Market does take time to digest this news. Hold onto your shares folks.
They have to get it back up over a buck. Nice.
Keep on radar for major short squeeze this week.
Cross over moving average bullish also.
9:04 am Abeona Therapeutics announces a direct placement of ~1.55 mln shares of registered common stock, at $5.50/share, with Soros Fund Management & Perceptive Life Science Fund groups (ABEO) : Co announced it had entered into a definitive purchase agreements with two healthcare institutional investors, Soros Fund Management and Perceptive Life Science Fund, and two Members of the Board of Directors, to raise $8.5 million in a direct placement of registered common stock.
The financing is comprised of 1,547,273 shares of common stock at a price of $5.50 per share.
Co plans to use the proceeds of the financing for the development of its proprietary rare disease programs, working capital and general corporate purposes.
trade 'em both ways and prospect as the saying goes. Buy gold too - good weekend all!
Don't discount the possibility of a share buyback either. My traders are different from my investments, and there are much bigger fish to fry like ITEK, DRYS, SD, both long and short. But today is golfing day!!
low float, just wait for next licensing deal, and of course there's more from company email. I don't invest long term without almost 30 years of doing DD. "...We have sufficient capital to support the ongoing research and development of our technology, and we have access to additional capital when needed.
However, it's important to distinguish between investing and trading before putting capital at risk. There is nothing wrong about either investing or trading; both activities have the same goal -- making money. Both require careful thought and discipline.
If one regards Lightbridge as an investment, then that person probably has considered the Company's operations, financial performance, capital structure, strategic direction, long-term market opportunity, competition and management's ability to execute a strategic plan successfully over time.
A trader typically is less concerned about business fundamentals and more focused on fluctuations in price, trading volume, money flow patterns and other short-term dynamics. Traders employ different tactics from buy-and-hold investors to achieve their objectives, such as short-selling, leverage (borrowing) and option trading.
Despite our progress and the promise of the Company's technology, Lightbridge has a relatively small number of shares outstanding, low trading volume....."
"...Despite volatility in capital markets over the past few days, Lightbridge is a fundamentally solid company with innovative proprietary technology and tremendous growth prospects in an expanding market with a global customer base of fuel fabricators and nuclear utilities.
Lightbridge is in its strongest position ever. Founded in 1992, the company has achieved several strategic milestones in 2014 and 2015 and is on track to realize high-margin revenue streams from technology licensing fees and other commercial arrangements...." (write him yourself if in doubt)
trading rules always apply. Sell at the open in a hot stock.